Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response

被引:445
作者
Liliensiek, B
Weigand, MA
Bierhaus, A
Nicklas, W
Kasper, M
Hofer, S
Plachky, J
Gröne, HJ
Kurschus, FC
Schmidt, AM
Du Yan, S
Martin, E
Schleicher, E
Stern, DM
Hämmerling, GJ
Nawroth, PP
Arnold, B
机构
[1] Heidelberg Univ, Dept Med 1, D-69120 Heidelberg, Germany
[2] Heidelberg Univ, Dept Anesthesiol, D-69120 Heidelberg, Germany
[3] German Canc Res Ctr, Div Tumor Immunol, Dept Mol Immunol, D-6900 Heidelberg, Germany
[4] German Canc Res Ctr, Dept Cent Anim Labs, D-6900 Heidelberg, Germany
[5] Tech Univ Dresden, Dept Anat, D-8027 Dresden, Germany
[6] German Canc Res Ctr, Dept Cellular & Mol Pathol, D-6900 Heidelberg, Germany
[7] Columbia Univ, Dept Pathol, New York, NY USA
[8] Columbia Univ, Dept Surg, New York, NY USA
[9] Dept Med 4, Tubingen, Germany
[10] Med Coll Georgia, Augusta, GA 30912 USA
关键词
D O I
10.1172/JCI200418704
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
While the initiation of the adaptive and innate immune response is well understood, less is known about cellular mechanisms propagating inflammation. The receptor for advanced glycation end products (RAGE), a transmembrane receptor of the immunoglobulin superfamily, leads to perpetuated cell activation. Using novel animal models with defective or tissue-specific RAGE expression, we show that in these animal models RAGE does not play a role in the adaptive immune response. However, deletion of RAGE provides protection from the lethal effects of septic shock caused by cecal ligation and puncture. Such protection is reversed by reconstitution of RAGE in endothelial and hematopoietic cells. These results indicate that the innate immune response is controlled by pattern-recognition receptors not only at the initiating steps but also at the phase of perpetuation.
引用
收藏
页码:1641 / 1650
页数:10
相关论文
共 62 条
[1]  
ABEL M, 1995, NEPHROL DIAL TRANSPL, V10, P1662
[2]   Toll signaling pathways in the innate immune response [J].
Anderson, KV .
CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (01) :13-19
[3]   NF-kappa B: Ten years after [J].
Baeuerle, PA ;
Baltimore, D .
CELL, 1996, 87 (01) :13-20
[4]  
BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141
[5]   Pro-inflammatory signaling:: Last pieces in the NF-κB puzzle [J].
Baeuerle, PA .
CURRENT BIOLOGY, 1998, 8 (01) :R19-R22
[6]   Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases [J].
Barnes, PJ ;
Larin, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) :1066-1071
[7]   Advanced glycation end products activate endothelium through signal-transduction receptor RAGE - A mechanism for amplification of inflammatory responses [J].
Basta, G ;
Lazzerini, G ;
Massaro, M ;
Simoncini, T ;
Tanganelli, P ;
Fu, CF ;
Kislinger, T ;
Stern, DM ;
Schmidt, AM ;
De Caterina, R .
CIRCULATION, 2002, 105 (07) :816-822
[8]   THE I-KAPPA-B PROTEINS - MULTIFUNCTIONAL REGULATORS OF REL/NF-KAPPA-B TRANSCRIPTION FACTORS [J].
BEG, AA ;
BALDWIN, AS .
GENES & DEVELOPMENT, 1993, 7 (11) :2064-2070
[9]   Diabetes-associated sustained activation of the transcription factor nuclear factor-κB [J].
Bierhaus, A ;
Schiekofer, S ;
Schwaninger, M ;
Andrassy, M ;
Humpert, PM ;
Chen, J ;
Hong, M ;
Luther, T ;
Henle, T ;
Klöting, I ;
Morcos, M ;
Hofmann, M ;
Tritschler, H ;
Weigle, B ;
Kasper, M ;
Smith, M ;
Perry, G ;
Schmidt, AM ;
Stern, DM ;
Häring, HU ;
Schleicher, E ;
Nawroth, PP .
DIABETES, 2001, 50 (12) :2792-2808
[10]   TREM-1 amplifies inflammation and is a crucial mediator of septic shock [J].
Bouchon, A ;
Facchetti, F ;
Weigand, MA ;
Colonna, M .
NATURE, 2001, 410 (6832) :1103-1107